deltatrials
Terminated NA INTERVENTIONAL 2-arm NCT00469599

Treatment of Secondary Hyperparathyroidism in the Uremic Patient

Treatment of Secondary Hyperparathyroidism in the Uremic Patient. A Study Comparing Alfacalcidol and Paricalcitol

Sponsor: Zealand University Hospital

Conditions Chronic Kidney Disease Secondary Hyperparathyroidism Vitamin D Deficiency
Interventions alfacalcidol paricalcitol
Updated 5 times since 2017 Last updated: Apr 1, 2011 Started: Jul 31, 2007 Primary completion: Sep 30, 2010 Completion: Oct 31, 2010
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Terminated after 86 pt included, because of recruitment problems

Other terminated trials from Zealand University Hospital

See all terminations from Zealand University Hospital

Other Chronic Kidney Disease trials with similar outcome

Browse all Chronic Kidney Disease trials

This NA trial investigates Chronic Kidney Disease and Secondary Hyperparathyroidism and is currently terminated or withdrawn. Zealand University Hospital leads this study, which shows 5 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated NA

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated NA

  5. Jan 2017 — Jun 2018 [monthly]

    Terminated NA

    First recorded

Jul 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Zealand University Hospital
Data source: Zealand University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations